The Study definition

The Study means the clinical study entitled “(Full title of protocol)
The Study means a study of a study of Environmental Impact Assessment (EIA) and Resettlement Action Plan (RAP) for the Project.
The Study. Laboratory shall render the Services as set forth in a Protocol and/or Scope of Work, Letter of Payment Authorization, Letter of Commitment or Consulting Services Letter (the Protocol and/or Scope of Work, Letter of Payment Authorization, Letter of Commitment and Consulting Services Letter are collectively referred to here as the "Supporting Documents"). A "Protocol" and/or "Scope of Work" shall mean an attachment to this Agreement describing the nature, design and scope of the Study and the schedule of work to be performed or consulting services to be provided during the course of an individual Study conducted by Laboratory for the Sponsor. A 'Letter of Payment Authorization" shall mean an attachment to this Agreement that describes with respect to a particular Study the price, fees and payment schedule for that Study and any modifications of the terms of this Agreement as applied to a particular Study. A "Letter of Commitment" shall mean an attachment to this Agreement that describes a commitment of space and resources by the Laboratory. A Consulting Services Letter shall mean an attachment to this Agreement that describes Laboratory's consulting services and pricing for such services. In the event of a conflict between the terms contained in the Supporting Documents and this Agreement, the terms of this Agreement shall control, unless specifically agreed upon to the contrary in the Supporting Documents. The Supporting Documents when signed by Laboratory and Sponsor shall he incorporated into and made a part of this Agreement.

Examples of The Study in a sentence

  • The Study is part of a multi-site study, and publication of the results of the Study conducted at the Site shall not be made before the first multi-site publication by Sponsor.

  • The Study shall be completed within ninety (90) Days from such fourth Disconnection Event (and each subsequent Disconnection Event) within any Contract Year, unless the Qualified Consultant determines the Study cannot reasonably be completed within ninety (90) Days, in which case, such longer period of time as the Qualified Consultant determines is necessary to complete the Study shall apply.

  • The Study will be performed with the data that is available to SCE at the time SCE begins to perform the Study.

  • The Study Process shall be used by an Interconnection Customer proposing to interconnect its Generating Facility with the Utility's System if the Generating Facility exceeds the size limits for the Section 3 Fast Track Process, is not certified, or is certified but did not pass the Fast Track Process or the 20 kW Inverter Process.

  • The Study described herein does not include review or analysis by third parties and also does not include a review by SCE of potential impacts of the Project on any third party systems or operations.

  • The Study location will not be changed without Medpace’s prior written consent.

  • The Study Sponsor will assess the AEs and may upgrade the Investigator’s assessment of seriousness and/or causality.

  • The Study Committee will comprise three representatives of the Association and three representatives appointed by the Board and the Committee will monitor this Accord and consider solutions to problems which may arise.

  • The Study Site shall not outsource, subcontract or delegate any of its obligations hereunder to a third party without the prior written consent of DSI.

  • The Study Site agrees to conduct the Study in accordance with the Protocol, based on the use of the Study Drug as described in the Investigators’ Brochure.


More Definitions of The Study

The Study means program of research concerning a retrospective assessment of the association between ctDNA detection and relapse-free survival using the Archer MRD Assay in patients with early stage breast TRAK-ER (randomised phase II trial of early detection of molecular relapse with circulating tumor DNA tracking and treatment with palbociclib plus fulvestrant versus standard endocrine therapy in patients with ER+/HER2- breast cancer), a the Study Protocol; (hereinafter, the "Study”).
The Study means that certain document commissioned by the City and prepared by Kaku Associates, Inc. dated May of 1991, as amended, Titled “A PARKING ANALYSIS FOR DOWNTOWN OJAI.”
The Study means one already mentioned. For good linkage: “This study / These studies.”
The Study means “The Study for Socio-Economic Reconstruction and Development of Conflict-Affected Areas in Mindanao”, which is composed of the implementation of Quick Impact Projects, assessment of the present conditions, In-depth analysis of selected barangays and formulation of Socio-Economic Development Plan for Conflict-Affected Areas.
The Study means South East Kowloon Development Comprehensive Planning and Engineering Review Stage 1 Planning Review.

Related to The Study

  • Phase 1 Trial means, with respect to a Licensed Product, a clinical trial (or — in case of a multi-phase clinical trial — those parts of a clinical trial) in line with the provisions of 21CFR312, Section 21 (a).

  • Phase 3 Study means a clinical study of a drug candidate in human patients that incorporates accepted endpoints for confirmation of statistical significance of efficacy and safety with the aim to obtain Regulatory Approval in any country as described in 21 C.F.R. 312.21(c), or a comparable clinical study prescribed by the relevant Regulatory Authority in a country other than the United States. The relevant drug candidate may be administered to patients as a single agent or in combination with other investigational or marketed agents.

  • Study means the investigation to be conducted in accordance with the Protocol.

  • Clinical Study means a Phase I Study, Phase II Study, Phase III Study, as applicable.

  • Phase III Trial means a Clinical Trial of an investigational product in subjects that incorporates accepted endpoints for confirmation of statistical significance of efficacy and safety with the aim to generate data and results that can be submitted to obtain Regulatory Approval as described in 21 C.F.R. 312.21(c), or a comparable Clinical Trial prescribed by the relevant Regulatory Authority in a country other than the United States.